The NIH announced a new policy on Thursday that bars research relying on taxpayer-funded grants, contracts, awards, and agreements from involving fetal tissue from elective abortions. The announced policy, effective immediately, comes one day before the March for Life in Washington, D.C.
NIH Director Jay Bhattacharya said the policy initiative comes as part of NIH’s dedication “to ensure that research supported by taxpayer funds is scientifically rigorous, ethically sound, and justified by a maximal return on the public’s investment.”
Research using human fetal tissue has been used in scientific experiments to develop various common vaccines, such as the polio vaccine. The research uses cell lines that come from aborted fetuses, raising serious ethical questions over their use, especially from the Catholic Church and advocates of
Continue reading
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!